FDA fast-tracks experimental virus vaccine by Moderna
The biotech company expects to start a late-stage study of the vaccine early in the northern hemisphere summer
12 May 2020 - 14:47
Bengaluru — Moderna said on Tuesday that the US Food and Drug Administration (FDA) granted “fast-track” designation to its experimental coronavirus vaccine to speed up the regulatory review process.
The company has been racing to develop a safe and effective vaccine against the novel coronavirus that has killed more than 288,000 people globally. It expects to start a late-stage study of the vaccine early in the northern hemisphere summer...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.